01 1Chantix
02 8Chantix/Champix
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 919
2019 Revenue in Millions : 1,107
Growth (%) : -17
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 398
2020 Revenue in Millions : 919
Growth (%) : -57
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 8
2021 Revenue in Millions : 398
Growth (%) : -98
Main Therapeutic Indication : Neuroscience and Mental Health
Currency : USD
2015 Revenue in Millions : 647
2014 Revenue in Millions : 671
Growth (%) : 4%
Main Therapeutic Indication : Neuroscience/Mental Health
Currency : USD
2014 Revenue in Millions : -0.30%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2016 Revenue in Millions : 842
2015 Revenue in Millions : 671
Growth (%) : 25
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 997
2016 Revenue in Millions : 842
Growth (%) : 18
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 1,084
2017 Revenue in Millions : 997
Growth (%) : 9%
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 1,107
2018 Revenue in Millions : 1,085
Growth (%) : 2
LOOKING FOR A SUPPLIER?